Compare CM & SYK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CM | SYK |
|---|---|---|
| Founded | 1867 | 1941 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 86.8B | 127.0B |
| IPO Year | 2023 | 1994 |
| Metric | CM | SYK |
|---|---|---|
| Price | $106.06 | $346.37 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 14 |
| Target Price | $107.50 | ★ $417.50 |
| AVG Volume (30 Days) | 1.6M | ★ 1.9M |
| Earning Date | 05-28-2026 | 04-30-2026 |
| Dividend Yield | ★ 2.83% | 1.01% |
| EPS Growth | N/A | ★ 8.25 |
| EPS | N/A | ★ 8.40 |
| Revenue | N/A | ★ $25,116,000,000.00 |
| Revenue This Year | $23.09 | $9.85 |
| Revenue Next Year | $4.65 | $8.36 |
| P/E Ratio | ★ $15.80 | $41.34 |
| Revenue Growth | N/A | ★ 11.16 |
| 52 Week Low | $58.00 | $319.32 |
| 52 Week High | $105.00 | $404.87 |
| Indicator | CM | SYK |
|---|---|---|
| Relative Strength Index (RSI) | 71.34 | 54.18 |
| Support Level | $90.69 | $328.23 |
| Resistance Level | N/A | $375.26 |
| Average True Range (ATR) | 1.76 | 7.69 |
| MACD | 1.19 | 3.05 |
| Stochastic Oscillator | 99.13 | 80.79 |
Canadian Imperial Bank of Commerce is Canada's fifth-largest bank with over CAD 1.1 trillion in assets at the end of fiscal 2025. It operates four business segments: Canadian retail and business banking, Canadian commercial banking and wealth management, US commercial banking and wealth management, and capital markets. It serves approximately 14 million personal banking and business customers, primarily in Canada and the US.
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one-fourth of Stryker's total revenue currently comes from outside the United States.